Skip to main content
. 2020 Jul 17;40(7):BSR20200995. doi: 10.1042/BSR20200995

Table 3. Genotype distributions in cases and controls for MTHFR C677T and A1298C polymorphisms in ovarian cancer.

Author Year Country Polymorphism Case Control
AA Aa aa AA Aa aa
Gao 2012 Asian C677T 97 100 27 232 178 22
Jakubowska 2012 Caucasian C677T 423 446 116 1447 1481 422
Ozkilic 2016 Middle Eastern C677T 18 28 4 19 30 5
Pawlik 2011 Caucasian C677T 67 55 13 63 79 18
Prasad 2011 Asian C677T 72 3 5 116 8 1
Terry# 2010 Caucasian C677T 427 492 140 499 488 138
Terry 2010 Caucasian C677T 71 72 10 210 217 55
Terry 2010 Caucasian C677T 164 167 33 193 168 51
Webb 2011 Caucasian C677T 744 709 185 571 568 139
Wu 2007 Asian C677T 17 40 24 32 35 13
Zhang 2012 Asian C677T 102 94 19 115 92 11
Song 2012 Asian A1298C 107 77 16 112 79 9
Terry 2010 Caucasian A1298C 515 430 93 534 450 109
Terry 2010 Caucasian A1298C 68 67 18 236 200 48
Terry 2010 Caucasian A1298C 173 149 42 189 180 43
Webb 2011 Caucasian A1298C 770 693 175 598 561 119

‘A’ represents wild-type allele and ‘a’ represents mutant allele.

#

Study separately genotyped subjects from three studies, the New England Case Control Study (NEC), Nurses’ Health Study (NHS), and Mayo Clinic Ovarian Cancer Case Control Study (MAY), thus were considered as three studies.